某医院住院患者活血化瘀类中药注射剂临床应用合理性评价  

Rational Evaluations of Clinical Application of Traditional Chinese Medicine Injections Activating Blood Circulation and Resolving Stasis in one Hospital

作　　者：吴春生[1] 吴应全[1] 陈浩涛[1] 郭越衡[1] 

机构地区：[1]揭阳市人民医院药学部,广东揭阳522000

出　　处：《药物流行病学杂志》2014年第12期745-747,754,共4页Chinese Journal of Pharmacoepidemiology

摘　　要：目的：调查某院活血化瘀类中药注射剂临床应用情况,为临床合理用药提供依据。方法：抽取某院2013年4~6月使用活血化瘀类中药注射剂的住院病历共1 678份,填写中药注射剂专项点评处方登记表,评价用药合理性。结果：用药不合理共1 636频次,占总用药频次比例为55.0%,不合理用药情况有：适应证不适宜、用法用量不适宜和联合用药不适宜等。结论：某院活血化瘀类中药注射剂不合理用药现象多见,应针对不合理用药原因采取干预措施,使临床用药合理。Objective ：To investigate the clinical application of traditional Chinese medicine injections activating blood circulation and resolving stasis （TCMIA） and promote its reasonable application. Methods：Selected 1 678 in-patient medical records application of TCMIA in one hospital from April to June in 2013 ,filled in the comment form and evaluated the application of TCMIA. Results： A total of 1 636 applications of TCM1A were irrational, the irrational use rate was 55.0%. There were many kinds of irrational TCMIA use, such as no indications, usage error and uncongenial drug combination. Conclusion：The irrational TCMIA use in our hospital was serious. Pharmaceutical intervention could be taken to promote that.

关 键 词：活血化瘀 中药注射剂 合理用药 药学干预 

分 类 号：R286[医药卫生—中药学]